首页> 外文OA文献 >Consequences of ChemR23 heteromerization with the chemokine receptors CXCR4 and CCR7.
【2h】

Consequences of ChemR23 heteromerization with the chemokine receptors CXCR4 and CCR7.

机译:ChemR23与趋化因子受体CXCR4和CCR7杂合的后果。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recent studies have shown that heteromerization of the chemokine receptors CCR2, CCR5 and CXCR4 is associated to negative binding cooperativity. In the present study, we build on these previous results, and investigate the consequences of chemokine receptor heteromerization with ChemR23, the receptor of chemerin, a leukocyte chemoattractant protein structurally unrelated to chemokines. We show, using BRET and HTRF assays, that ChemR23 forms homomers, and provide data suggesting that ChemR23 also forms heteromers with the chemokine receptors CCR7 and CXCR4. As previously described for other chemokine receptor heteromers, negative binding cooperativity was detected between ChemR23 and chemokine receptors, i.e. the ligands of one receptor competed for the binding of a specific tracer of the other. We also showed, using mouse bone marrow-derived dendritic cells prepared from wild-type and ChemR23 knockout mice, that ChemR23-specific ligands cross-inhibited CXCL12 binding on CXCR4 in a ChemR23-dependent manner, supporting the relevance of the ChemR23/CXCR4 interaction in native leukocytes. Finally, and in contrast to the situation encountered for other previously characterized CXCR4 heteromers, we showed that the CXCR4-specific antagonist AMD3100 did not cross-inhibit chemerin binding in cells co-expressing ChemR23 and CXCR4, demonstrating that cross-regulation by AMD3100 depends on the nature of receptor partners with which CXCR4 is co-expressed.
机译:最近的研究表明趋化因子受体CCR2,CCR5和CXCR4的异聚与负结合协同作用有关。在本研究中,我们基于这些先前的结果,并研究了趋化因子受体与ChemR23的化学趋化因子受体异源化的结果。我们显示,使用BRET和HTRF分析,ChemR23形成同聚体,并提供数据表明ChemR23也与趋化因子受体CCR7和CXCR4形成异聚体。如先前对于其他趋化因子受体异聚体所述,在ChemR23和趋化因子受体之间检测到负结合协同作用,即一个受体的配体竞争另一受体的特异性示踪剂的结合。我们还显示,使用从野生型和ChemR23基因敲除小鼠制备的小鼠骨髓来源的树突状细胞,ChemR23特异性配体以ChemR23依赖性方式交叉抑制CXCL12与CXCR4的结合,从而支持ChemR23 / CXCR4相互作用的相关性在天然白细胞中。最后,与其他先前表征的CXCR4异源异构体所遇到的情况相反,我们表明CXCR4特异性拮抗剂AMD3100在交叉表达ChemR23和CXCR4的细胞中没有交叉抑制凯莫瑞结合,表明AMD3100的交叉调节取决于与CXCR4共表达的受体伴侣的性质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号